Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 938-754-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Sucrose and glycerol, reaction products with C12-18, C18unsatd. fatty acids
- Molecular formula:
- Representative, generic structures are given in "structural formula" wherein R = H or fatty acid residue and R' = sucrose residue, glycerol residue, H or alkali. Additional citric acid resp. its salt is present.
- IUPAC Name:
- Sucrose and glycerol, reaction products with C12-18, C18unsatd. fatty acids
- Test material form:
- semi-solid (amorphous): gel
- Remarks:
- migrated information: paste
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: no data
- Weight at study initiation: m: 182 - 201g; f: 167 - 209g
- Fasting period before study: 16 hours
- Housing: collective caging, cage type: Macrolon type IlI./max. 5
- Diet: ad libitum; Ssniff Spezialdiäten GmbH, 4770 Soest/Westfalen
- Water: ad libitum; Macrolon dringking bottles, Becker & Co. 4620 Castrop-Rauxel
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 2
- Humidity (%): 50 - 80
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 hours daily, fluorescent light, 120 lux
IN-LIFE DATES:
From: 09.08.1989 To: 24.08.1989
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- 20% dispersion
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 20% dispersion
- Amount of vehicle (if gavage): no data
The test substance wa heated up to about 37°C and diluted with Aqua deion. by using a magnetic stirrer in order to get a 20 % dispersion.
The pH-value was 7.9.
MAXIMUM DOSE VOLUME APPLIED: 2.1 mL - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Range finding study:
Two female rats were employed in a preliminary range finding study. The dosage of the single oral administration was 2000 mg/kg bw. This preliminary study showed no mortalities.
Main study:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: the body weights were recorded at day 0 (beginning of the experiment), at day 7 and at day 14 (terminal necropsy) on the surviving animals.
- Necropsy of survivors performed: yes
- Clinical signs: the evaluation of the clinical-toxicological signs (a modified Irwin-Screening by Screening methods in pharmacology, R. A. Turner, 1965) was done individually and depends on the nature of the signs. If the symptoms persist to the same degree for a longer period of time, this was noted in the corresponding protocols. Records were made according to the following intervals: approx. 20', 1 h, 2 + 3 h, 6 h, 24 h, thereafter once daily up to day 14.
Observation:
Records were made according to the following intervals: approx. 20', 1 h, 2+3 h, 6 h, 24 h, thereafter once daily up to day 14.
Results and discussion
- Preliminary study:
- Two female rats were employed in a preliminary range finding study. The dosage of the single oral administration was 2000 mg/kg bw. This preliminary study showed no mortalities.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no
- Clinical signs:
- other: The sampIe induced during the entire observation period of 14 days no clinical-/toxicological symptoms.
- Gross pathology:
- Necropsies performed on all animals at the end of the 14-day observation period showed no test compound-related macroscopic findings in the cranial-, thoracic- and abdominal cavity.
Any other information on results incl. tables
The LD50 deterrnination showed the following result: 24 h + 14 days, male + female > 2000 mg/kg bw
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: other: CLP, EU GHS (Regulation (EC) No 1272/2008) and DSD (Directive 67/548/EEC)
- Conclusions:
- The toxicity after a single oral intake of the test sample is above the dose limit 2000 mg/kg bw. The substances does not need to be classified according to CLP, EU GHS (Regulation (EC) No 1272/2008) and according to DSD (Directive 67/548/EEC).
- Executive summary:
In an acute oral toxicity study (limit test) performed according to the OECD Guideline 401 (Acute Oral Toxicity), groups of fasted Wistar rats (5/sex)
were given a single oral dose of Sucroglyceride C12-18, C18unsatd. in water at a dose of 2000 mg/kg bw and observed for 14 days.
Oral LD50:
Males > 2000 mg/kg bw
Females > 2000 mg/kg bw
Combined > 2000 mg/kg bw
There were no treatment related clinical signs, necropsy findings or changes in body weight.
Sucroglyceride C12-18, C18unsatd. is practically nontoxic based on the LD50 in males/females.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.